Hyper IgM syndromes
- 1 July 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 15 (4), 422-429
- https://doi.org/10.1097/00002281-200307000-00009
Abstract
The immune defense against extracellular pathogens is largely dependent on antibody production. Class switch recombination and somatic hypermutation shape the secondary antibody repertoire in peripheral lymphoid tissue. In the past few years, a series of primary immune deficiencies characterized by defects in these processes and collectively referred to as hyper-IgM syndromes, have been described. Careful investigation of these rare "experiments of nature" has enabled to identify novel genes and molecular events that drive terminal B-cell differentiation. Abnormalities in these genes are likely involved also in lymphoid tumorigenesis and autoimmunity.Keywords
This publication has 59 references indexed in Scilit:
- Elucidation of a downstream boundary of the 3′ IgH regulatory regionMolecular Immunology, 2003
- Critical Roles of Activation-Induced Cytidine Deaminase in the Homeostasis of Gut FloraScience, 2002
- DCs induce CD40-independent immunoglobulin class switching through BLyS and APRILNature Immunology, 2002
- Hyper-IgM syndromes: a model for studying the regulation of class switch recombination and somatic hypermutation generationBiochemical Society Transactions, 2002
- AID is required to initiate Nbs1/γ-H2AX focus formation and mutations at sites of class switchingNature, 2001
- Immunologic Reconstitution Following Bone Marrow Transplantation for X-Linked Hyper IgM SyndromeClinical Immunology, 2001
- Transcription-induced Cleavage of Immunoglobulin Switch Regions by Nucleotide Excision Repair Nucleases in VitroJournal of Biological Chemistry, 2000
- The Liaison of Isotype Class Switch and Mismatch RepairThe Journal of Experimental Medicine, 1999
- IMMUNE REGULATION BY CD40 AND ITS LIGAND GP39Annual Review of Immunology, 1996
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993